Dienhart M K, Downs S M
Biology Department, Marquette University, Milwaukee, Wisconsin 53201-1881, USA.
Zygote. 1996 May;4(2):129-37. doi: 10.1017/s0967199400003002.
Hypoxanthine can block preimplantation mouse embryo development in vitro at the 2- to 4-cell stages, and this has recently been shown to be reversed by cAMP-elevating agents. However, the extent of this hypoxanthine-induced arrest is determined by the culture conditions and strain of mouse. Whitten's and KSOM/AA are two embryo culture media that support preimplantation development to the blastocyst stage. This study was undertaken to examine the influence of several components in these media on hypoxanthine-arrested preimplantation mouse embryos and to test the hypothesis that reversal of the hypoxanthine block by cAMP-elevating agents requires cooperative interaction with the chelator, EDTA. Initial experiments demonstrated that embryo development was blocked in the presence of hypoxanthine in Whitten's medium but not in KSOM/AA; furthermore, removal of EDTA from KSOM/AA rendered this medium incapable of supporting high levels of development to blastocyst (9%), whereas high numbers of blastocysts (80%) formed in Whitten's medium, which does not contain the chelator. Consequently, Whitten's medium was used to test our hypothesis. It has previously been demonstrated that the phosphodiesterase inhibitor, IBMX, can reverse the developmental arrest imposed by hypoxanthine in EDTA-supplemented Earle's basic salt solution, but in the present study the addition of IBMX to Whitten's medium resulted in a block to development and failed to reverse the hypoxanthine arrest. These disparate effects can be explained by the presence or absence of EDTA. Supplementing Whitten's medium with EDTA reverses the IBMX effect, but not the hypoxanthine-induced block. While IBMX alone is unable to reverse the hypoxanthine block in Whitten's medium, development is greatly enhanced by the simultaneous addition of EDTA and IBMX. Similar results were obtained with the cAMP analogue, 8-AHA-cAMP. The data therefore support our hypothesis that the reversal of the hypoxanthine-induced arrest by cAMP-elevating agents is critically dependent on the presence of EDTA. We contrast this with the situation in mouse oocytes, where the hypoxanthine-induced meiotic arrest is not reversed by the addition of EDTA and/or cAMP-elevating agents.
次黄嘌呤可在体外阻止植入前小鼠胚胎在2至4细胞阶段的发育,最近有研究表明,提高cAMP的试剂可逆转这种情况。然而,次黄嘌呤诱导的发育停滞程度取决于培养条件和小鼠品系。惠滕氏培养基和KSOM/AA是两种支持植入前胚胎发育至囊胚阶段的培养基。本研究旨在探讨这些培养基中的几种成分对次黄嘌呤阻滞的植入前小鼠胚胎的影响,并检验以下假设:提高cAMP的试剂逆转次黄嘌呤阻滞需要与螯合剂乙二胺四乙酸(EDTA)协同作用。初步实验表明,在惠滕氏培养基中存在次黄嘌呤时胚胎发育受阻,而在KSOM/AA中则不然;此外,从KSOM/AA中去除EDTA后,该培养基无法支持高水平的囊胚发育(9%),而在不含螯合剂的惠滕氏培养基中则形成大量囊胚(80%)。因此,使用惠滕氏培养基来检验我们的假设。此前有研究表明,磷酸二酯酶抑制剂异丁基甲基黄嘌呤(IBMX)可逆转在添加EDTA的厄尔氏基础盐溶液中次黄嘌呤导致的发育停滞,但在本研究中,向惠滕氏培养基中添加IBMX导致发育阻滞,未能逆转次黄嘌呤阻滞。这些不同的效应可以用EDTA的存在与否来解释。向惠滕氏培养基中添加EDTA可逆转IBMX的作用,但不能逆转次黄嘌呤诱导的阻滞。虽然单独使用IBMX无法逆转惠滕氏培养基中的次黄嘌呤阻滞,但同时添加EDTA和IBMX可大大促进发育。使用cAMP类似物8-氮杂腺苷-环磷酸腺苷(8-AHA-cAMP)也得到了类似结果。因此,数据支持我们的假设,即提高cAMP的试剂逆转次黄嘌呤诱导的阻滞关键取决于EDTA的存在。我们将此与小鼠卵母细胞的情况进行对比,在小鼠卵母细胞中,添加EDTA和/或提高cAMP的试剂并不能逆转次黄嘌呤诱导的减数分裂阻滞。